Xi Calls for US-China Cooperation on AI Governance at Trump Summit
The joint statement by both heads of state signals that AI regulation has become a formal bilateral policy agenda item, with concrete commitments still unspecified in public records.
Chinese President Xi Jinping stated Thursday that the United States and China share an obligation to keep artificial intelligence development under human control, making the remarks as a summit with President Donald Trump commenced, according to The Hill. Xi described both nations as "leading nations" in the AI industry and said each carries responsibility for managing the technology's trajectory.
The summit marks a continuation of high-level US-China engagement that The Congressional Times previously reported on in Trump and Xi Meet at White House to Address Trade, AI, and Iran. Thursday's session extended that engagement with AI governance moved to a more prominent position on the stated agenda.
Xi's framing of AI as a shared governance responsibility carries direct policy implications for the United States. Federal agencies including the Commerce Department's Bureau of Industry and Security and the National Institute of Standards and Technology have active regulatory proceedings governing AI export controls and risk management standards, respectively. Any bilateral commitment made at the summit level could shape those proceedings.
On the US side, the Trump administration has not publicly released a formal AI governance framework specific to US-China coordination as of September 24, 2026. The White House Office of Science and Technology Policy, which would typically coordinate such a framework, has not published a joint communique in connection with Thursday's summit as of the time of publication. What such a document would contain remains unknown. A White House press release or joint statement, if issued, would constitute the primary public record of any specific commitment.
The question of what "human control" means in operational terms is unresolved in existing international agreements. The United Nations has convened an advisory body on AI governance, but the US and China have not signed a binding bilateral AI treaty as of the current date. Xi's remarks, as reported, did not specify enforcement mechanisms, timelines, or the scope of covered AI systems.
The AI sector is directly affected by the bilateral relationship through existing export control rules. The Commerce Department's Entity List and associated Export Administration Regulations restrict the transfer of certain advanced semiconductors and AI-related technologies to Chinese entities. As of the most recent BIS update prior to this summit, restrictions on advanced chips, including those governed by the October 2023 and subsequent October 2024 export control rules, remained in effect. Whether Thursday's summit discussions include any modification to those rules is not stated in available public records.
Congress has maintained a parallel track on AI and China policy. The House Select Committee on the Chinese Communist Party, established in the 118th Congress and renewed in the 119th, has issued reports recommending tighter controls on AI technology transfer. Senate Commerce Committee members from both parties have introduced legislation addressing AI standards. No floor votes directly linking US-China AI diplomacy to domestic legislation are scheduled as of September 24, 2026, according to the Senate's published legislative calendar.
The economic dimension of AI governance talks is significant. US companies with AI-related revenue streams exposed to the Chinese market include major technology firms whose aggregate market capitalization exceeds several trillion dollars, according to public SEC filings from those companies. Any bilateral agreement affecting market access or technology transfer rules would have material consequences for those filings, though the scope of Thursday's discussions has not been confirmed in a formal document.
Historically, US-China science and technology agreements have required Senate advice and consent when structured as treaties, or have proceeded as executive agreements when framed under existing presidential authority. The 1979 US-China Agreement on Cooperation in Science and Technology has been renewed multiple times and provides one legal framework under which executive AI cooperation could proceed without a Senate vote. Whether Thursday's summit produces an action under that framework or a new instrument is unknown.
What remains publicly unresolved after Thursday's session: whether any joint statement was signed, what specific commitments on AI safety or export controls were exchanged, and whether any modification to existing BIS rules is under negotiation. A White House press release, a State Department fact sheet, or a BIS rulemaking notice in the Federal Register would each constitute verifiable public records answering those questions.